Edition:
United Kingdom

Ambu A/S (AMBUb.CO)

AMBUb.CO on Copenhagen Stock Exchange

100.35DKK
3:59pm BST
Change (% chg)

kr.-3.65 (-3.51%)
Prev Close
kr.104.00
Open
kr.103.55
Day's High
kr.104.30
Day's Low
kr.99.88
Volume
918,453
Avg. Vol
1,608,238
52-wk High
kr.279.60
52-wk Low
kr.85.30

Latest Key Developments (Source: Significant Developments)

Ambu Appoints New CEO
Friday, 10 May 2019 

May 10 (Reuters) - Ambu A/S ::REG-AMBU A/S: AMBU APPOINTS NEW CEO.APPOINTED JUAN-JOSÉ GONZALEZ AS NEW CEO,.REPLACEMENT OF CEO DOES NOT CHANGE ANNOUNCED FINANCIAL EXPECTATIONS FOR 2018/19.NEW CEO, EFFECTIVE MAY 15, 2019, TO REPLACE LARS MARCHER WHO RESIGNS FROM HIS POSITION..IN RELATION TO LARS MARCHER'S RESIGNATION, THERE WILL BE ONE-OFF COSTS OF APPROX. DKK 38M, WHICH FOR ACCOUNTING PURPOSES WILL BE RECOGNIZED IN INCOME STATEMENT AS SPECIAL ITEMS.PLANNED PRODUCT LAUNCHES UP TO END OF FINANCIAL YEAR 2019/20 AND AMBU'S PROGRAM FOR UPCOMMING DDW CONGRESS IN SAN DIEGO ON 18-21 MAY 2019 IS THUS UNAFFECTED BY THIS.  Full Article

Ambu Q2 EBIT Rises To DKK 195 Million
Wednesday, 1 May 2019 

May 1 (Reuters) - Ambu A/S ::REG-AMBU A/S: INTERIM REPORT FOR Q2 2018/19 AND FOR THE PERIOD 1 OCTOBER 2018 - 31 MARCH 2019.REG-AMBU A/S: INTERIM REPORT FOR Q2 2018/19 AND FOR THE PERIOD 1 OCTOBER 2018 - 31 MARCH 2019.Q2 2018/19 REVENUE DKK 785M MILLION VERSUS DKK 651 MILLION YEAR AGO.OVERALL, THIS WAS AMBU'S BEST-EVER QUARTER.SALES OF ENDOSCOPES REACHED 182,000 UNITS FOR QUARTER AND 331,000 UNITS FOR H1.WE ARE CONFIDENT THAT TOTAL SALES OF AT LEAST 750,000 ENDOSCOPES WILL BE ACHIEVED BY END OF YEAR -CEO.OUTLOOK FOR FULL YEAR ANNOUNCED IN INTERIM REPORT FOR Q1 2018/19 ON 31 JANUARY 2019 IS MAINTAINED.Q2 2018/19 EBIT DKK 195 MILLION VERSUS DKK 156 MILLION YEAR AGO.AMBU REALISED ORGANIC GROWTH OF 14% IN Q2.AT END OF MARCH, WE LAUNCHED A NEW SINGLE-USE ENDOSCOPE FOR ENT PROCEDURES IN EUROPE, AND WE EXPECT TO LAUNCH PRODUCTS IN US MARKET BEFORE SUMMER -CEO.Q2 WAS A QUARTER OF MANY SUCCESSES, AND WE ARE UP TO SPEED ON ALL IMPORTANT PARAMETERS BEFORE START OF H2 -CEO.  Full Article

Ambu Q3 EBIT Rises To DKK 151 Million
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - Ambu A/S ::REG-AMBU A/S: INTERIM REPORT Q3 2017/18.TARGET FOR SALES OF ENDOSCOPES IS INCREASED TO 550,000 UNITS..RAISES ITS OUTLOOK FOR THIS YEAR'S EBIT MARGIN BY 1 PERCENTAGE POINT.Q3 2017/18 REVENUE DKK 673 MILLION VERSUS DKK 601 MILLION YEAR AGO.OUTLOOK FOR ORGANIC GROWTH IN LOCAL CURRENCIES IS CHANGED FROM PREVIOUSLY 'APPROX. 14-15%' TO A MORE PRECISE 'APPROX. 15%'.Q3 2017/18 EBIT DKK 151 MILLION VERSUS DKK 130 MILLION YEAR AGO.EBIT MARGIN OUTLOOK IS RAISED FROM PREVIOUSLY 'APPROX. 20-21%' TO NOW 'APPROX. 21-22%'..SALES OF ENDOSCOPES IN Q3 REACHED 146,000 UNITS, UP 54% RELATIVE TO Q3 LAST YEAR..  Full Article

Ambu Reduces Nominal Value Of Each A And B Share​
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Ambu A/S ::‍DECIDED TO REDUCE NOMINAL VALUE OF EACH A AND B SHARE FROM DKK 2.50 PER SHARE TO DKK 0.50 PER SHARE.​.- ‍EACH A- OR B-SHARE OF NOM. VALUE DKK 2.50 WILL THUS BE SPLIT IN FIVE NEW A- OR B-SHARES OF NOM VALUE DKK 0.50 PER SHARE​.  Full Article

Ambu Q4 2016/17 EBIT up at DKK ‍134​ million
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - AMBU A/S :Q4 2016/17 EBIT DKK ‍134​ MILLION VERSUS DKK 131 MILLION YEAR AGO.‍OUTLOOK FOR 2017/18 IS UNCHANGED RELATIVE TO MOST RECENTLY ANNOUNCED OUTLOOK ON 25 OCTOBER 2017​.AMBU A/S - ‍Q4 2016/17 ORGANIC GROWTH OF 14% (8%) WAS REALISED IN Q4 IN LOCAL CURRENCIES, BASED ON REVENUE OF DKK 629M (DKK 573M)​.  Full Article

Ambu buys Invendo Medical for EUR 225 million
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - AMBU A/S ::REG-AMBU ACQUIRES INVENDO MEDICAL AND ENTERS MARKET OF 70 MILLION GASTRO PROCEDURES ANNUALLY.‍PURCHASE PRICE OF EUR 225 MILLION INCLUDES CONTINGENT PAYMENTS OF UP TO EUR 110 MILLION.​.‍IMPACT FROM ACQUISITION TO AMBU'S 2017/18 GUIDANCE IS MINIMAL.​.‍EBIT-MARGIN WAS EXPECTED AT INTERVAL 20-21% AND IS NOW EXPECTED AROUND 20%.​.‍FREE CASH FLOW BEFORE ACQUISITIONS WAS EXPECTED OF DKK 275-300 MILLION AND IS NOW EXPECTED AT AROUND DKK 275 MILLION​.  Full Article

Ambu plans to ‍generate an EBIT margin of 24-25 pct in 2020
Wednesday, 4 Oct 2017 

Oct 4 (Reuters) - AMBU A/S :AMBU A/S: AMBU LAUNCHES AMBITIOUS STRATEGY TOWARDS 2020.‍TOWARDS 2020 AMBU PLANS TO GROW ORGANICALLY BY 13-15% ANNUALLY AND EXPAND EBIT-MARGIN BY MORE THAN 5%-PTS​.PLANS TO ‍GENERATE AN EBIT MARGIN IN LEVEL OF 24-25% IN 2020.AMBU A/S - ‍AIMS TO DOUBLE REVENUE IN THREE YEARS​.‍OUTLOOK FOR FINANCIAL YEAR 2016/17 REMAINS UNCHANGED​.‍FOR FINANCIAL YEAR 2017/18, AMBU EXPECTS AN ORGANIC GROWTH RATE IN LEVEL OF 13%, AN EBIT-MARGIN IN INTERVAL 20-21%​.  Full Article

Ambu Q3 2016/17 EBIT up at DKK 130 million
Wednesday, 23 Aug 2017 

Aug 23 (Reuters) - AMBU A/S ::‍OUTLOOK FOR 2016/17 IS RAISED​.‍OUTLOOK IS NOW FOR ORGANIC GROWTH OF APPROX. 14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 12-14%​.‍FREE CASH FLOWS OF APPROX. DKK 300M ARE NOW EXPECTED AGAINST EARLIER EXPECTATIONS OF DKK 250-275M​.Q3 2016/17 REVENUE DKK 601 ‍​ MILLION VERSUS DKK 517 MILLION YEAR AGO.Q3 2016/17 EBIT DKK 130 ‍​ MILLION VERSUS DKK 94 MILLION YEAR AGO.  Full Article